.rll-youtube-player .play{--wpr-bg-00c6882d-8cb5-4c7b-ad35-f464353ae0c2: url('https://catchingnews.com/wp-content/plugins/wp-rocket/assets/img/youtube.png');}.perfmatters-lazy-youtube .play{--wpr-bg-26d5735f-8125-4e20-a649-70310b108c39: url('https://catchingnews.com/wp-content/plugins/perfmatters/img/youtube.svg');}

Day: January 18, 2022

Stocks to Invest

CASI Pharmaceuticals, Inc. (CASI) Stock Declining in The Early Trading. Here’s why

CASI Pharmaceuticals, Inc. (CASI) is a leading biopharmaceutical company engaged in the development and commercialization of hematology and oncology-related diseases. The lead pipeline candidates of

Stocks to Invest

Summit Wireless Technologies, Inc. (WISA) Stock Dropping in Early Trading. Here’s the Reason.

Summit Wireless Technologies, Inc. (WISA) is an innovative company developing spatial and wireless sound expertise for smart tools and next-generation home entertainment platforms. The company

Trendy Stocks

Pluristem Therapeutics, Inc. (PSTI) Stock Leaping Forward in Premarket, Here’s What you Should Know

Pluristem Therapeutics, Inc. (PSTI) is engaged in the production of cell-based product lines for commercial use. The company focuses on the development of regenerative medicine

Equity Investing

My Size, Inc. (MYSZ) Stock Shining in Aftermarket, Here’s What you Should Know.

My Size, Inc. (MYSZ) is a developer of mobile sophisticated algorithm solutions with its applications in vast industry including apparel, DIY, shipping, and parcel delivery

Market Insights

Spero Therapeutics, Inc. (SPRO) Stock Roaring in Aftermarket Despite any Visible Reason.

Spero Therapeutics, Inc. (SPRO) is an innovative clinical-stage biotherapeutics company engaged in the development and commercialization of products for the treatment of multi-drug-resistant bacterial infections.

Stocks to Invest

Lipocine, Inc. (LPCN) Stock Sinking in the Aftermarket, Here’s What you Should Know.

Lipocine, Inc. (LPCN) is an innovative clinical-stage biotherapeutics firm engaged in drug production for metabolic and endocrine disorders. The lead product candidates of the company

Trendy Stocks

Here’s What you Should Know About Aftermarket Skyrocketing Avinger, Inc. (AVGR) Stock

Avinger, Inc. (AVGR) is a medical device company engaged in the design and development of catheter-based, image-guided platforms to diagnose and treat patients with Peripheral

Catching News are non-trivial topics and publications about how you make money and properly dispose of it. We tell about business and entrepreneurship, start-ups, success stories. We also specialize in economic news.

Day: January 18, 2022

CASI Pharmaceuticals, Inc. (CASI) Stock Declining in The Early Trading. Here’s why

Summit Wireless Technologies, Inc. (WISA) Stock Dropping in Early Trading. Here’s the Reason.

Pluristem Therapeutics, Inc. (PSTI) Stock Leaping Forward in Premarket, Here’s What you Should Know

My Size, Inc. (MYSZ) Stock Shining in Aftermarket, Here’s What you Should Know.

Spero Therapeutics, Inc. (SPRO) Stock Roaring in Aftermarket Despite any Visible Reason.

Lipocine, Inc. (LPCN) Stock Sinking in the Aftermarket, Here’s What you Should Know.

Here’s What you Should Know About Aftermarket Skyrocketing Avinger, Inc. (AVGR) Stock

Popular Articles

Mars Mission Boosts Rocket Lab (RKLB) Stock Performance

Aldeyra (ALDX) Stock Climbs Substantially After Positive Clinical Trial Outcome

Surge In Above Food (ABVE) Stock After Announcing Strategic Acquisition

Important Links